Anti‐cytokine targeted therapies for ANCA‐associated vasculitis

Review of 4 RCTs (n=440) found moderate‐certainty evidence that in patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis, mepolizumab probably decreases disease relapse vs placebo.

Cochrane Database of Systematic Reviews